Azimuth Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $17.7M | Sell |
109,361
-4,085
| -4% | -$593K | 0.76% | 36 |
|
|
2021
Q4 | $15.4M | Sell |
113,446
-5,590
| -5% | -$660K | 0.62% | 58 |
|
|
2021
Q3 | $12.8M | Sell |
119,036
-1,007
| -0.8% | -$115K | 0.55% | 65 |
|
|
2021
Q2 | $13.5M | Buy |
120,043
+1,437
| +1% | +$162K | 0.58% | 60 |
|
|
2021
Q1 | $12.8M | Buy |
118,606
+4,652
| +4% | +$498K | 0.61% | 59 |
|
|
2020
Q4 | $12.2M | Buy |
113,954
+1,400
| +1% | +$135K | 0.61% | 58 |
|
|
2020
Q3 | $9.86M | Sell |
112,554
-3,595
| -3% | -$338K | 0.58% | 64 |
|
|
2020
Q2 | $11.4M | Sell |
116,149
-899
| -0.8% | -$79.2K | 0.73% | 51 |
|
|
2020
Q1 | $8.92M | Sell |
117,048
-1,340
| -1% | -$114K | 0.67% | 54 |
|
|
2019
Q4 | $10.5M | Sell |
118,388
-1,990
| -2% | -$165K | 0.64% | 58 |
|
|
2019
Q3 | $9.12M | Buy |
120,378
+18,758
| +18% | +$1.29M | 0.59% | 66 |
|
|
2019
Q2 | $7.39M | Buy |
101,620
+30,980
| +44% | +$2.44M | 0.49% | 74 |
|
|
2019
Q1 | $5.69M | Sell |
70,640
-303
| -0.4% | -$24.8K | 0.38% | 91 |
|
|
2018
Q4 | $6.54M | Sell |
70,943
-3,066
| -4% | -$270K | 0.5% | 67 |
|
|
2018
Q3 | $7M | Sell |
74,009
-2,206
| -3% | -$209K | 0.47% | 79 |
|
|
2018
Q2 | $7.06M | Sell |
76,215
-1,685
| -2% | -$165K | 0.51% | 77 |
|
|
2018
Q1 | $7.37M | Sell |
77,900
-3,485
| -4% | -$383K | 0.54% | 70 |
|
|
2017
Q4 | $7.87M | Sell |
81,385
-3,410
| -4% | -$321K | 0.57% | 67 |
|
|
2017
Q3 | $7.54M | Buy |
84,795
+2,152
| +3% | +$164K | 0.56% | 68 |
|
|
2017
Q2 | $5.99M | Buy |
82,643
+375
| +0.5% | +$25.2K | 0.47% | 79 |
|
|
2017
Q1 | $5.36M | Sell |
82,268
-120
| -0.1% | -$7.54K | 0.43% | 84 |
|
|
2016
Q4 | $5.16M | Buy |
82,388
+1,783
| +2% | +$109K | 0.44% | 78 |
|
|
2016
Q3 | $5.08M | Sell |
80,605
-1,750
| -2% | -$113K | 0.44% | 84 |
|
|
2016
Q2 | $5.1M | Sell |
82,355
-190
| -0.2% | -$11.6K | 0.46% | 82 |
|
|
2016
Q1 | $4.71M | Buy |
82,545
+500
| +0.6% | +$27.9K | 0.45% | 83 |
|
|
2015
Q4 | $4.86M | Sell |
82,045
-2,500
| -3% | -$144K | 0.47% | 79 |
|
|
2015
Q3 | $4.6M | Buy |
84,545
+400
| +0.5% | +$26K | 0.48% | 78 |
|
|
2015
Q2 | $5.65M | Sell |
84,145
-750
| -0.9% | -$49K | 0.55% | 66 |
|
|
2015
Q1 | $4.97M | Buy |
84,895
+1,292
| +2% | +$78.1K | 0.48% | 76 |
|
|
2014
Q4 | $5.47M | Buy |
83,603
+50
| +0.1% | +$3.15K | 0.56% | 59 |
|
|
2014
Q3 | $4.83M | Sell |
83,553
-3,881
| -4% | -$215K | 0.53% | 64 |
|
|
2014
Q2 | $4.93M | Sell |
87,434
-4,588
| -5% | -$241K | 0.55% | 65 |
|
|
2014
Q1 | $4.73M | Sell |
92,022
-7,812
| -8% | -$395K | 0.57% | 60 |
|
|
2013
Q4 | $5.27M | Buy |
99,834
+23,500
| +31% | +$1.15M | 0.63% | 51 |
|
|
2013
Q3 | $3.41M | Buy |
76,334
+30,016
| +65% | +$1.33M | 0.47% | 78 |
|
|
2013
Q2 | $1.92M | Buy |
+46,318
| New | +$2.03M | 0.34% | 97 |
|
Other funds holding ABBV
Azimuth Capital Management's ABBV Position: Q1 2022 in Review
Azimuth Capital Management reduced its AbbVie (ABBV) stake by 3.6% in Q1 2022, selling an estimated $593K and leaving 109,361 shares worth $17.7M. The position accounts for 0.76% of the portfolio, ranked #36.
Azimuth Capital Management first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Azimuth Capital Management held 109,361 shares of AbbVie worth $17.7M as of Q1 2022.
- Azimuth Capital Management sold 4,085 AbbVie shares in Q1 2022, an estimated $593K.
- AbbVie made up 0.76% of Azimuth Capital Management's portfolio in Q1 2022, its #36 holding.
- Azimuth Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.